Taylor Swift assists recording artists, Apple Music, and (even) herself from ipcloseup.wordpress.com Taylor Swift, a pop star with sufficient power to move mountains, succeeded last year in moving an equally resolute object: Apple Music’s position on paying royalties to recording artists. A year later it is ...
Share via E–mail | Twitter | Facebook
Google Anti-Piracy Report Criticized by Content Owners from www.ip-watch.org Google is doing more to counter online copyright infringement than ever before, it said in its “How Google Fights Piracy 2016 Update,” claiming takedowns of over 500 million webpages in response to rights holder requests ...
Share via E–mail | Twitter | Facebook
WTO DG Sees Positive Changes, More Engagement; Would Consider A Second Term from www.ip-watch.org World Trade Organization Director General Roberto Azevêdo today said he would consider a second mandate at the head of the organisation. He also described a positive momentum in the organisation in the first semester of ...
Share via E–mail | Twitter | Facebook
South African Government Staves Off Critics With IP Consultative Framework from www.ip-watch.org South Africa’s Department of Trade and Industry (DTI) appears to be meeting its detractors halfway with a new intellectual property consultative framework it says will help pave the way for consultative engagement with IP ...
Share via E–mail | Twitter | Facebook
Network Information Management Patent Invalid Under 35 U.S.C. § 101 from docketreport.blogspot.com The court granted defendants' motion to dismiss because the asserted claims of plaintiff’s network information management patent encompassed unpatentable subject matter and found that the claims were directed toward an abstract idea. "Plaintiff responds ...
Share via E–mail | Twitter | Facebook
Illumina v. Ariosa: the CAFC discusses the phrase “relating to” from ipbiz.blogspot.com The outcome of Illumina v. Ariosa
Illumina, Inc. (“Illumina”) appeals a district court order
denying Illumina’s motion to compel arbitration.
Illumina and Ariosa Diagnostics, Inc. (“Ariosa”) entered
into a supply agreement in which the ... Share via E–mail | Twitter | Facebook
Many Hepatitis C Patients Do Not Have Access To Medicines In India, Group Says from www.ip-watch.org Despite being the global leader of generic drug manufacturing, access to hepatitis C treatment in India remains out of reach for a large portion of the population, a civil society group has said in a ...
Share via E–mail | Twitter | Facebook
This is Why You Have an Editor: Politics, Plagiarism, and Copyright from www.iposgoode.ca The inescapable world of U.S. politics, especially in an election year, consistently offers much legal debate. Somewhat less often, politicians and their entourages accidentally wade into the domain of intellectual property law. Politicians have ...
Share via E–mail | Twitter | Facebook
US Senate Judiciary Chairman Questions High Cost Of Medicare Drug Coverage from www.ip-watch.org United States Senate Judiciary Committee Chairman Charles Grassley, an Iowa Republican, has demanded answers from the government Medicare programme regarding the rapid rise in costs of coverage of Americans’ prescription drugs. The demand follows a ...
Share via E–mail | Twitter | Facebook
Libraries, Groups Welcome WIPO Copyright Appointment, With Hope from www.ip-watch.org A range of highly active groups at the World Intellectual Property Organization representing libraries, archives, and digital civil liberties this week welcomed the appointment of a copyright industry lobbyist to lead WIPO copyright issues. But ...
Share via E–mail | Twitter | Facebook
They Invented What? (No. 8) from anticipatethis.wordpress.com Originally posted on
Anticipate This!™ | Patent and Trademark Law Blog:
U.S. Pat. No. 6,982,161: Process for the utilization of ruminant animal methane emissions. I claim: 1. A method for producing methane-utilizing microorganisms ...
Share via E–mail | Twitter | Facebook
Genzyme Therapeutic Products Ltd. v. Biomarin Pharmaceutical Inc. (Fed. Cir. 2016) from www.patentdocs.org By Kevin E. Noonan -- The Federal Circuit affirmed the decision by the Patent Trial and Appeals Board (PTAB) in an inter partes review (IPR) that the claims of Genzyme's U.S Patent Nos. 7 ...
Share via E–mail | Twitter | Facebook